6 October 2024

Howe Street Reporter Title

Tag: Specialty pharma

  • First Glance with Jody Vance – Medexus Pharma (MDP.T)

    First Glance with Jody Vance – Medexus Pharma (MDP.T)

    Vancouver’s own Jody Vance speaks with Ken d’Entremont, Medexus Pharmaceuticals (MDP.V) CEO and director, to find out more about the company’s mandate of bringing established drugs approved in other countries to patients in Canada. Listen in! <div algn=”center:><iframe width=”803″ height=”452″ src=”https://www.youtube.com/embed/r4MwrGgePDo” title=”YouTube video player” frameborder=”0″ allow=”accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture” allowfullscreen></iframe></div>

  • Medexus Pharmaceuticals (MDP.V), poised for flight on the Nasdaq (coming soon)

    If you are like me and health sciences is your sector of choice when it comes to investing in the markets, you’d better be very patient, love doing research – and a willingness to see it through!!! A sector famous for its high-risk-high-reward characteristics is definitely not recommended for the faint of heart. Lucky for…